{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:48:29Z","timestamp":1791254909755,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/sj.bjc.6605249","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T20:00:17Z","timestamp":1251230417000},"page":"1183-1193","source":"Crossref","is-referenced-by-count":43,"title":["VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo"],"prefix":"10.1038","volume":"101","author":[{"given":"E S","family":"Rennel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H R","family":"Varey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D O","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"BF6605249_CR1","unstructured":"Artac RA, McFee RM, Longfellow Smith RA, Baltes-Breitwisch MM, Clopton DT, Cupp AS (in press) Neutralization of vascular endothelial growth factor inhibitory isoforms is more effective than treatment with angiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary. Biol Reprod"},{"key":"BF6605249_CR2","first-page":"4123","volume":"62","author":"DO Bates","year":"2002","unstructured":"Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62: 4123\u20134131","journal-title":"Cancer Res"},{"key":"BF6605249_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1042\/CS20050292","volume":"110","author":"DO Bates","year":"2006","unstructured":"Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ (2006) The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin Sci (Lond) 110: 575\u2013585","journal-title":"Clin Sci (Lond)"},{"key":"BF6605249_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/CS20080270","volume":"116","author":"VL Bills","year":"2009","unstructured":"Bills VL, Varet J, Millar A, Harper SJ, Soothill PW, Bates DO (2009) Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clin Sci (Lond) 116: 265\u2013272","journal-title":"Clin Sci (Lond)"},{"key":"BF6605249_CR5","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1096\/fj.08-107219","volume":"22","author":"S Cebe-Suarez","year":"2008","unstructured":"Cebe-Suarez S, Grunewald FS, Jaussi R, Li X, Claesson-Welsh L, Spillmann D, Mercer AA, Prota AE, Ballmer-Hofer K (2008) Orf virus VEGF-E NZ2 promotes paracellular NRP-1\/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J 22: 3078\u20133086","journal-title":"FASEB J"},{"key":"BF6605249_CR6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00018-006-6254-9","volume":"63","author":"S Cebe Suarez","year":"2006","unstructured":"Cebe Suarez S, Pieren M, Cariolato L, Arn S, Hoffmann U, Bogucki A, Manlius C, Wood J, Ballmer-Hofer K (2006) A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell Mol Life Sci 63: 2067\u20132077","journal-title":"Cell Mol Life Sci"},{"key":"BF6605249_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1095\/biolreprod48.5.1120","volume":"48","author":"DS Charnock-Jones","year":"1993","unstructured":"Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 48: 1120\u20131128","journal-title":"Biol Reprod"},{"key":"BF6605249_CR8","first-page":"532","volume":"15","author":"P Chomczynski","year":"1993","unstructured":"Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532\u2013534, 536-7","journal-title":"Biotechniques"},{"key":"BF6605249_CR9","doi-asserted-by":"publisher","first-page":"F767","DOI":"10.1152\/ajprenal.00337.2003","volume":"286","author":"TG Cui","year":"2004","unstructured":"Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, Harper SJ (2004) Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am J Physiol Renal Physiol 286: F767\u2013F773","journal-title":"Am J Physiol Renal Physiol"},{"key":"BF6605249_CR10","first-page":"1517","volume":"14","author":"C Ergorul","year":"2008","unstructured":"Ergorul C, Ray A, Huang W, Darland D, Luo ZK, Grosskreutz CL (2008) Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma. Mol Vis 14: 1517\u20131524","journal-title":"Mol Vis"},{"key":"BF6605249_CR11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1210\/mend-5-12-1806","volume":"5","author":"KA Houck","year":"1991","unstructured":"Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806\u20131814","journal-title":"Mol Endocrinol"},{"key":"BF6605249_CR12","first-page":"752","volume":"40","author":"L Jingjing","year":"1999","unstructured":"Jingjing L, Xue Y, Agarwal N, Roque RS (1999) Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 40: 752\u2013759","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6605249_CR13","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1158\/0008-5472.CAN-07-6577","volume":"68","author":"H Kawamura","year":"2008","unstructured":"Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L (2008) Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res 68: 4683\u20134692","journal-title":"Cancer Res"},{"key":"BF6605249_CR14","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","volume":"271","author":"BA Keyt","year":"1996","unstructured":"Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271: 7788\u20137795","journal-title":"J Biol Chem"},{"key":"BF6605249_CR15","first-page":"626","volume":"12","author":"O Konopatskaya","year":"2006","unstructured":"Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA (2006) VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12: 626\u2013632","journal-title":"Mol Vis"},{"key":"BF6605249_CR16","first-page":"5565","volume":"60","author":"CG Lee","year":"2000","unstructured":"Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y (2000) Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60: 5565\u20135570","journal-title":"Cancer Res"},{"key":"BF6605249_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306\u20131309","journal-title":"Science"},{"key":"BF6605249_CR18","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1242\/jcs.016410","volume":"121","author":"DG Nowak","year":"2008","unstructured":"Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO (2008) Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 121: 3487\u20133495","journal-title":"J Cell Sci"},{"key":"BF6605249_CR19","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1007\/s00125-005-1951-8","volume":"48","author":"RM Perrin","year":"2005","unstructured":"Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ (2005) Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48: 2422\u20132427","journal-title":"Diabetologia"},{"key":"BF6605249_CR20","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.1074\/jbc.272.11.7151","volume":"272","author":"Z Poltorak","year":"1997","unstructured":"Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G (1997) VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272: 7151\u20137158","journal-title":"J Biol Chem"},{"key":"BF6605249_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.bjc.6603839","volume":"97","author":"RO Pritchard-Jones","year":"2007","unstructured":"Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, Harper SJ, Bates DO (2007) Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer 97: 223\u2013230","journal-title":"Br J Cancer"},{"key":"BF6605249_CR22","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1096\/fj.07-9718com","volume":"22","author":"Y Qiu","year":"2008","unstructured":"Qiu Y, Bevan H, Weeraperuma S, Wratting D, Murphy D, Neal CR, Bates DO, Harper SJ (2008) Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J 22: 1104\u20131112","journal-title":"FASEB J"},{"key":"BF6605249_CR23","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/sj.bjc.6604309","volume":"98","author":"E Rennel","year":"2008","unstructured":"Rennel E, Waine E, Guan H, Schuler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman E, Bates D, Harper S (2008a) The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer 98: 1250\u20131257","journal-title":"Br J Cancer"},{"key":"BF6605249_CR24","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.ejca.2008.05.027","volume":"44","author":"ES Rennel","year":"2008","unstructured":"Rennel ES, Hamdollah-Zadeh MA, Wheatley ER, Magnussen A, Schuler Y, Kelly SP, Finucane C, Ellison D, Cebe-Suarez S, Ballmer-Hofer K, Mather S, Stewart L, Bates DO, Harper SJ (2008b) Recombinant human VEGF165b protein is an effective anti-cancer agent in mice. Eur J Cancer 44: 1883\u20131894","journal-title":"Eur J Cancer"},{"key":"BF6605249_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1681\/ASN.2006020124","volume":"18","author":"VA Schumacher","year":"2007","unstructured":"Schumacher VA, Jeruschke S, Eitner F, Becker JU, Pitschke G, Ince Y, Miner JH, Leuschner I, Engers R, Everding AS, Bulla M, Royer-Pokora B (2007) Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. J Am Soc Nephrol 18: 719\u2013729","journal-title":"J Am Soc Nephrol"},{"key":"BF6605249_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"DR Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (NY) 219: 983\u2013985","journal-title":"Science (NY)"},{"key":"BF6605249_CR27","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D\u2032Amato R, Sullivan R, D\u2019Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6605249_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/sj.bjc.6604308","volume":"98","author":"AH Varey","year":"2008","unstructured":"Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, Harper SJ, Bates DO (2008) VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 98: 1366\u20131379","journal-title":"Br J Cancer"},{"key":"BF6605249_CR29","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1096\/fj.07-0504ufm","volume":"21","author":"MA von Wronski","year":"2007","unstructured":"von Wronski MA, Tweedle MF, Nunn AD (2007) Binding of the C-terminal amino acids of VEGF121 directly with neuropilin-1 should be considered. FASEB J 21: 1292; author reply 1293","journal-title":"FASEB J"},{"key":"BF6605249_CR30","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1158\/0008-5472.CAN-04-0934","volume":"64","author":"J Woolard","year":"2004","unstructured":"Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64: 7822\u20137835","journal-title":"Cancer Res"},{"key":"BF6605249_CR31","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","volume":"93","author":"F Yuan","year":"1996","unstructured":"Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor\/vascular permeability factor antibody. Proc Natl Acad Sci USA 93: 14765\u201314770","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605249_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1054\/bjoc.2000.1279","volume":"83","author":"HT Zhang","year":"2000","unstructured":"Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R (2000) The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83: 63\u201368","journal-title":"Br J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605249","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:41:27Z","timestamp":1684413687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BF6605249"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605249","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}